// App-Quantinova.ai

: Does Social Disadvantage Modify the Association Between Health Rating and Disruption Due to COVID-19 Among Adults With Hypertension

Researchers

Presenter

  • Onoriode Kesiena

Principal Investigators

  • Aysha Allahverdiyeva

  • Mehdi Rizvi

  • Jacob Braunstein

  • Kobina Hagan

  • Navin Kumar

  • Shreyas Singireddy

  • Kofi D Seffah

  • Temitope Olokunlade

  • Reed Mszar

  • Elias Mossialos

  • Garima Sharma

  • Khurram Nasir

Medical Centers

  • Johns Hopkins, Baltimore, MD

  • Piedmont Athens Regional Med, Athens, GA

  • Houston Methodist Hospital, Houston, TX

  • Houston Methodist Hospital, Houston, TX

  • Piedmont, Athens, GA

  • London Sch of Economics, London

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Infectious Diseases (ID)

Disease

  • Hypertension

  • Coronavirus disease

Biomarkers

  • Scavenger Receptor Class A Member 3

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved